Recent Analysis on Pertussis (Whooping Cough) - Pipeline Review, H1 2016

Pertussis (Whooping Cough) - Pipeline Review, H1 2016 ​is a new market research publication announced by Reportstack. This report provides an overview of the Pertussis (Whooping Cough) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pertussis (Whooping Cough), complete with analysis by stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pertussis (Whooping Cough) and features dormant and discontinued projects.

The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

To view the table of contents and know more details, please visit ​Pertussis (Whooping Cough) - Pipeline Review, H1 2016.

Scope

- The report provides a snapshot of the global therapeutic landscape of Pertussis (Whooping Cough)
- The report reviews pipeline therapeutics for Pertussis (Whooping Cough) by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report summarizes all the dormant and discontinued pipeline projects 
- The report reviews latest news related to pipeline therapeutics for Pertussis (Whooping Cough)

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Pertussis (Whooping Cough)
- Identify potential new clients or partners in the target demographic

Companies Mentioned

Beijing Minhai Biotechnology Co., Ltd Beijing Tiantan Biological Products Co., Ltd. Bharat Biotech International Limited Biological E. Limited Boryung Pharmaceutical Co., Ltd. Daiichi Sankyo Company, Limited DBV Technologies S.A. GlaxoSmithKline Plc Green Cross Corporation ILiAD Biotechnologies, LLC Indian Immunologicals Limited LG Life Science LTD. NanoBio Corporation Panacea Biotec Limited Sanofi Pasteur SA Serum Institute of India Limited Sinovac Biotech Ltd. Synthetic Biologics, Inc. Zydus Cadila Healthcare Limited

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###